severe cases

[키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age antiviral response antiviral responses article association Biomarker can not caused clinical evolution clinical manifestation clinical manifestations clinical status Comparative complex coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patients Critical critical COVID-19 patients critical patients cytokine Cytokines database demonstrated determine disease severity elevated evaluated Evidence evidence of healthy individual healthy individuals IFN-α IFN-I IFN-α immunological alteration infections interferon interferon response interferons Level limit of detection marker means Meta-analysis Mild mild cases Mild disease no significant difference outcome outcomes Pathogenesis Patient patients performed peripheral plasma Plasma levels plasma protein random effect Reporting respiratory Result resulting review SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus severe cases Severe patient severity severity of COVID-19 Sex significant difference SMD standardized mean difference the MEDLINE Type Type I IFN type I interferon type I interferons was measured was performed Web of Science with mild disease
[DOI] 10.3389/fimmu.2021.657363 PMC 바로가기 [Article Type] Meta-Analysis